Christopher Mohr
Amgen (United States)(US)Université Bourgogne Franche-Comté(FR)Essen University Hospital(DE)
Publications by Year
Research Areas
Reconstructive Surgery and Microvascular Techniques, Reconstructive Facial Surgery Techniques, Cancer Mechanisms and Therapy, Synthesis and biological activity, Head and Neck Surgical Oncology
Most-Cited Works
- → The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity(2019)2,188 cited
- → Discovery of a Covalent Inhibitor of KRASG12C (AMG 510) for the Treatment of Solid Tumors(2019)691 cited
- → Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)(2006)365 cited
- → A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation(1999)317 cited
- → Spheno-orbital meningiomas: interdisciplinary surgical approach, resectability and long-term results(2005)115 cited
- → Unfolded Protein Response in Cancer: IRE1α Inhibition by Selective Kinase Ligands Does Not Impair Tumor Cell Viability(2014)104 cited